RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Kainos Laboratories

Kainos Laboratories ROE 2024

Kainos Laboratories ROE

0.1

Kainos Laboratories Dividend yield

2.81 %

Ticker

4556.T

ISIN

JP3205650009

In 2024, Kainos Laboratories's return on equity (ROE) was 0.1, a 3.34% increase from the 0.1 ROE in the previous year.

Kainos Laboratories Aktienanalyse

What does Kainos Laboratories do?

Kainos Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Kainos Laboratories's Return on Equity (ROE)

Kainos Laboratories's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Kainos Laboratories's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Kainos Laboratories's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Kainos Laboratories’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Kainos Laboratories Stock

What is the ROE (Return on Equity) of Kainos Laboratories this year?

The ROE of Kainos Laboratories this year is 0.1 undefined.

How has the Return on Equity (ROE) of Kainos Laboratories developed compared to the previous year?

The ROE of Kainos Laboratories has increased by 3.34% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Kainos Laboratories?

A high ROE indicates that Kainos Laboratories generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Kainos Laboratories?

A low ROE can indicate that Kainos Laboratories is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Kainos Laboratories affect the company?

A change in ROE (Return on Equity) of Kainos Laboratories can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Kainos Laboratories?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Kainos Laboratories?

Some factors that can influence Kainos Laboratories's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Kainos Laboratories pay?

Over the past 12 months, Kainos Laboratories paid a dividend of 32 JPY . This corresponds to a dividend yield of about 2.81 %. For the coming 12 months, Kainos Laboratories is expected to pay a dividend of 32 JPY.

What is the dividend yield of Kainos Laboratories?

The current dividend yield of Kainos Laboratories is 2.81 %.

When does Kainos Laboratories pay dividends?

Kainos Laboratories pays a quarterly dividend. This is distributed in the months of April, April, April, April.

How secure is the dividend of Kainos Laboratories?

Kainos Laboratories paid dividends every year for the past 16 years.

What is the dividend of Kainos Laboratories?

For the upcoming 12 months, dividends amounting to 32 JPY are expected. This corresponds to a dividend yield of 2.81 %.

In which sector is Kainos Laboratories located?

Kainos Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von Kainos Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Kainos Laboratories from 6/1/2024 amounting to 32 JPY, you needed to have the stock in your portfolio before the ex-date on 3/28/2024.

When did Kainos Laboratories pay the last dividend?

The last dividend was paid out on 6/1/2024.

What was the dividend of Kainos Laboratories in the year 2023?

In the year 2023, Kainos Laboratories distributed 25 JPY as dividends.

In which currency does Kainos Laboratories pay out the dividend?

The dividends of Kainos Laboratories are distributed in JPY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Kainos Laboratories

Our stock analysis for Kainos Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Kainos Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.